You are here: Industry Insights > dengue vaccine

News List

Takeda’s dengue vaccine bags positive long-term efficacy results pharmatimes
May 26, 2021
Japanese pharma company Takeda has announced that its dengue vaccine candidate TAK-003 demonstrated continued protection through three years after vaccination, regardless of previous exposure to the disease.
Sanofi’s dengue vaccine secures FDA approval pharmaceutical-technology
May 05, 2019
Sanofi has received approval from the US Food and Drug Administration (FDA) for Dengvaxia, a vaccine that is designed to prevent all four dengue disease serotypes.
WHO recommends testing before use of Sanofi’s dengue vaccine expressbpd
April 23, 2018
The French drugmaker warned in November that Dengvaxia, first approved in late 2015, could increase the risk of severe dengue in some cases in people who had not been previously exposed to the disease.
The Philippines Suspends Sanofi's Dengue Vaccine After 730,000+ Children are Immunized biospace
December 05, 2017
Sanofi announced that the dengue vaccine may actually worsen the condition and that the government Philippines has ordered the investigation of the following more than 730,000 children for immunization.
World’s First Dengue Vaccine Dengvaxia into Market Plight Mr. Nanguo
November 21, 2017
Performance of the dengue vaccine—Dengvaxia that is placed high hopes on by Sanofi is not optimistic, although the dengue is still running riot.
Director upheaval threatens Brazilian dengue vaccine program, scientists say fiercepharma
March 08, 2017
Progress on a late-stage dengue vaccine candidate developed by U.S. scientists is threatened as its licensee—the Butantan Institute in Brazil—recently lost its top boss.